Roles of Human CYP2A6 and Monkey CYP2A24 and 2A26 Cytochrome P450 Enzymes in the Oxidation of 2,5,29,59-Tetrachlorobiphenyl

被引:25
|
作者
Shimada, Tsutomu [1 ]
Kakimoto, Kensaku [2 ]
Takenaka, Shigeo [1 ]
Koga, Nobuyuki [3 ]
Uehara, Shotaro [4 ]
Murayama, Norie [4 ]
Yamazaki, Hiroshi [4 ]
Kim, Donghak [5 ]
Guengerich, F. Peter [6 ]
Komori, Masayuki [1 ]
机构
[1] Osaka Prefecture Univ, Lab Cellular & Mol Biol, Izumisano, Osaka, Japan
[2] Osaka Prefectural Inst Publ Hlth, Higashinari Ku, Osaka, Japan
[3] Nakamura Gakuen Univ, Fac Nutr Sci, Johnan Ku, Fukuoka, Japan
[4] Showa Pharmaceut Univ, Lab Drug Metab & Pharmacokinet, Machida, Tokyo, Japan
[5] Konkuk Univ, Dept Biol Sci, Seoul, South Korea
[6] Vanderbilt Univ, Sch Med, Dept Biochem, Nashville, TN 37235 USA
基金
日本学术振兴会;
关键词
CONGENER-SPECIFIC ANALYSIS; RAT-LIVER MICROSOMES; POLYCHLORINATED-BIPHENYLS; ESCHERICHIA-COLI; NADPH-P450; REDUCTASE; CATALYTIC-ACTIVITIES; HEPATIC MICROSOMES; CYNOMOLGUS MONKEYS; HAMSTER LIVER; AMINO-ACID;
D O I
10.1124/dmd.116.072991
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
2,5,2',5'-Tetrachlorobiphenyl (TCB) induced type I binding spectra with cytochrome P450 (P450) 2A6 and 2A13, with Ks values of 9.4 and 0.51 mM, respectively. However, CYP2A6 oxidized 2,5,2',5'-TCB to form 4-hydroxylated products at a much higher rate (similar to 1.0 minute(-1)) than CYP2A13 (similar to 0.02 minute(-1)) based on analysis by liquid chromatography-tandem mass spectrometry. Formation of 4-hydroxy-2,5,2',5'-TCB by CYP2A6 was greater than that of 3-hydroxy-2,5,2',5'-TCB and three other hydroxylated products. Several human P450 enzymes, including CYP1A1, 1A2, 1B1, 2B6, 2D6, 2E1, 2C9, and 3A4, did not show any detectable activities in oxidizing 2,5,2',5'-TCB. Cynomolgus monkey CYP2A24, which shows 95% amino acid identity to human CYP2A6, catalyzed 4-hydroxylation of 2,5,2',5'-TCB at a higher rate (similar to 0.3 minute(-1)) than CYP2A26 (93% identity to CYP2A6, similar to 0.13 minute(-1)) and CYP2A23 (94% identity to CYP2A13, similar to 0.008 minute(-1)). None of these human and monkey CYP2A enzymes were catalytically active in oxidizing other TCB congeners, such as 2,4,3',4'-, 3,4,3',4'-, and 3,5,3',5'-TCB. Molecular docking analysis suggested that there are different orientations of interaction of 2,5,2',5'-TCB with the active sites (over the heme) of human and monkey CYP2A enzymes, and that ligand interaction energies (U values) of bound protein-ligand complexes show structural relationships of interaction of TCBs and other ligands with active sites of CYP2A enzymes. Catalytic differences in human and monkey CYP2A enzymes in the oxidation of 2,5,2',5'-TCB are suggested to be due to amino acid changes at substrate recognition sites, i.e., V110L, I209S, I300F, V365M, S369G, and R372H, based on the comparison of primary sequences.
引用
收藏
页码:1899 / 1909
页数:11
相关论文
共 50 条
  • [41] Effects of Genetic Polymorphisms of Drug Transporter ABCB1 (MDR1) and Cytochrome P450 Enzymes CYP2A6, CYP2B6 on Nicotine Addiction and Smoking Cessation
    Muderrisoglu, Ahmet
    Babaoglu, Elif
    Korkmaz, Elif Tugce
    Ongun, Mert C.
    Karabulut, Erdem
    Iskit, Alper B.
    Emri, Salih
    Babaoglu, Melih O.
    FRONTIERS IN GENETICS, 2020, 11
  • [42] Cytochrome P4502A6 (CYP2A6) expression in human hepatocellular carcinoma
    Raunio, H
    Juvonen, R
    Pasanen, M
    Pelkonen, O
    Pääkkö, P
    Soini, Y
    HEPATOLOGY, 1998, 27 (02) : 427 - 432
  • [43] Eicosapentaenoic acid metabolism by cytochrome P450 enzymes of the CYP2C subfamily
    Barbosa-Sicard, E
    Markovic, M
    Honeck, H
    Christ, B
    Muller, DN
    Schunck, WH
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2005, 329 (04) : 1275 - 1281
  • [44] Differential Expression of Cytochrome P450 Enzymes from the CYP2C Subfamily in the Human Brain
    Depaz, Iris M. Booth
    Toselli, Francesca
    Wilce, Peter A.
    Gillam, Elizabeth M. J.
    DRUG METABOLISM AND DISPOSITION, 2015, 43 (03) : 353 - 357
  • [45] The P450 oxidoreductase (POR) rs2868177 and cytochrome P450 (CYP) 2B6*6 polymorphisms contribute to the interindividual variability in human CYP2B6 activity
    Gao, Li-chen
    Liu, Fang-qun
    Yang, Li
    Cheng, Lin
    Dai, Hai-ying
    Tao, Ran
    Cao, Shi-Peng
    Wang, Di
    Tang, Jie
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2016, 72 (10) : 1205 - 1213
  • [46] The P450 oxidoreductase (POR) rs2868177 and cytochrome P450 (CYP) 2B6*6 polymorphisms contribute to the interindividual variability in human CYP2B6 activity
    Li-chen Gao
    Fang-qun Liu
    Li Yang
    Lin Cheng
    Hai-ying Dai
    Ran Tao
    Shi-Peng Cao
    Di Wang
    Jie Tang
    European Journal of Clinical Pharmacology, 2016, 72 : 1205 - 1213
  • [47] RNA Editing Enzymes Modulate the Expression of Hepatic CYP2B6, CYP2C8, and Other Cytochrome P450 Isoforms
    Nozaki, Kaori
    Nakano, Masataka
    Iwakami, Chika
    Fukami, Tatsuki
    Nakajima, Miki
    DRUG METABOLISM AND DISPOSITION, 2019, 47 (06) : 639 - 647
  • [48] Cloning of cytochrome P450, CYP6P5, and CYP6AA2 from Anopheles minimus resistant to deltamethrin
    Rongnoparut, P
    Boonsuepsakul, S
    Chareonviriyaphap, T
    Thanomsing, N
    JOURNAL OF VECTOR ECOLOGY, 2003, 28 (02) : 150 - 158
  • [49] Synthetic Models Related to Methoxalen and Menthofuran-Cytochrome P450 (CYP) 2A6 Interactions. Benzofuran and Coumarin Derivatives as Potent and Selective Inhibitors of CYP2A6
    Yamaguchi, Yuki
    Akimoto, Ichie
    Motegi, Kyoko
    Yoshimura, Teruki
    Wada, Keiji
    Nishizono, Naozumi
    Oda, Kazuaki
    CHEMICAL & PHARMACEUTICAL BULLETIN, 2013, 61 (10) : 997 - 1001
  • [50] The effect of lycopene on the total cytochrome P450, CYP1A2 and CYP2E1
    Louisa, Melva
    Suyatna, Frans D.
    Setiawati, Arini
    Jusman, Sri W. A.
    MEDICAL JOURNAL OF INDONESIA, 2009, 18 (04) : 233 - 238